Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ULSCs by RESTEM for Polymyositis: Likelihood of Approval
ULSCs is under clinical development by RESTEM and currently in Phase I for Polymyositis. According to GlobalData, Phase I drugs...
ULSCs by RESTEM for Dermatomyositis: Likelihood of Approval
ULSCs is under clinical development by RESTEM and currently in Phase I for Dermatomyositis. According to GlobalData, Phase I drugs...
ULSCs by RESTEM for Gastrointestinal Bleeding (Gastrointestinal Hemorrhage): Likelihood of Approval
ULSCs is under clinical development by RESTEM and currently in Phase I for Gastrointestinal Bleeding (Gastrointestinal Hemorrhage). According to GlobalData,...
ULSCs by RESTEM for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
ULSCs is under clinical development by RESTEM and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory...